Core Laboratories is a cheap, cash-generative oilfield-services name with rising earnings estimates and a 28.7% gap to the analyst target, held back by declining revenue, no competitive moat, 25% short interest and a confirmed downtrend.
Thesis pillars
- Attractive Valuation Vs Target↓Deteriorating
- Rising Estimates Earnings Beat Streak↓Deteriorating
- Excellent Cash Conversion No Moat→Stable
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Oct 24, 2026, based on the 10-K filed Mar 23, 2026
Core Laboratories Inc. (CLB) Stock Analysis
Recovery setup · Inst Constrain edge
Energy · Oil & Gas Equipment & Services
Hold if already holding. Not a fresh buy at $10.49, but acceptable to hold if already in. Reasons: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Below 200-MA, MA slope -6.5%/30d (confirmed downtrend).
We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, primarily through client relationships with many of the world's major,... Read more
Hold if already holding. Not a fresh buy at $10.49, but acceptable to hold if already in. Reasons: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Below 200-MA, MA slope -6.5%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 55. Mixed signals. Hold existing position. Score 5.3/10, moderate confidence.
Passes 6/8 gates (positive momentum, favorable risk/reward ratio, clean insider activity, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Suitability: speculative.
Recent developments
updated 2026-10-29Recent Developments — Core Laboratories Inc.
Latest news
- NEWS Core Laboratories (NYSE:CLB) Issues Earnings Results - MarketBeat — MarketBeat neutral
- NEWS Core Laboratories (NYSE:CLB) Releases Q3 2026 Earnings Guidance - MarketBeat — MarketBeat neutral
- NEWS Core Laboratories (NYSE:CLB) Misses Q2 CY2026 Sales Expectations - StockStory — StockStory negative
- NEWS Is Core Laboratories Inc (CLB) Undervalued After Q2 Earnings Mis - GuruFocus — GuruFocus positive
- NEWS Core Laboratories Reports Mixed Q2 2026 Results, Boosts Liquidity - TipRanks — TipRanks neutral
Generated 2026-10-29T11:08:50Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Material Events(8-K, last 90d)
- 2026-08-25Item 5.02MEDIUM(d) | | Exhibits 17.1 [Letter dated August 25, 2026 from Mr. Temeng to the Board of Directors of Core Laboratories Inc.](https://www.sec.gov/Archives/edgar/data/1958086/000119312526365271/clb-ex17_1.htm) 104 [... truncated]SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Analyst Consensus
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $10.49, but acceptable to hold if already in. Reasons: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Below 200-MA, MA slope -6.5%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 55. Mixed signals. Hold existing position. Analyst target $12.75 (+21.5%), stop $9.76 (−7.5%), A.R:R 1.7:1. Score 5.3/10, moderate confidence.
Analyst target: $12.75 (+21.5% upside). Analyst target $12.75 (+21.5%), stop $9.76 (−7.5%), A.R:R 1.7:1. Stop-loss: $9.76.
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.5); Below 200-MA, MA slope -6.5%/30d (confirmed downtrend).
Core Laboratories Inc. trades at a P/E of 20.2 (forward 15.2). TrendMatrix value score: 7.9/10. Verdict: Hold.
7 analysts cover CLB with a consensus score of 3.7/5. Average price target: $15.
What does Core Laboratories Inc. do?We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir...
We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, primarily through client relationships with many of the world's major, national and independent oil companies. These services and products can enable our clients to evaluate and improve reservoir performance and increase oil and gas recovery from their new and existing fields.